Loading clinical trials...
Loading clinical trials...
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a researc...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Target PharmaSolutions, Inc.
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT06318169 · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
NCT05842512 · Nonalcoholic Steatohepatitis (NASH)
NCT06335771 · Obesity, Nonalcoholic Fatty Liver, and more
NCT03587831 · NASH - Nonalcoholic Steatohepatitis
Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic
Phoenix, Arizona
Stanford University
Palo Alto, California
California Liver Research Institute
Pasadena, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions